PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group

MLA

Fuchs, Michael, et al. “PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group.” Blood, vol. 132, no. 1, Number 1 Supplement 1, Nov. 2018, p. 925. EBSCOhost, https://doi.org/10.1182/blood-2018-99-114519.

APA

Fuchs, M., Goergen, H., Kobe, C., Eich, H., Baues, C., Greil, R., Sasse, S., Zijlstra, J. M., Lohri, A., Rosenwald, A., von Tresckow, B., Diehl, V., Kuhnert, G., Dietlein, M., Borchmann, P., & Engert, A. (2018). PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group. Blood, 132(1, Number 1 Supplement 1), 925. https://doi.org/10.1182/blood-2018-99-114519

Chicago

Fuchs, Michael, Helen Goergen, Carsten Kobe, Hans Eich, Christian Baues, Richard Greil, Stephanie Sasse, et al. 2018. “PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group.” Blood 132 (1, Number 1 Supplement 1): 925. doi:10.1182/blood-2018-99-114519.